Children and adolescents treated with fremanezumab experienced fewer migraine and headache days compared with placebo, according to an abstract presented at the American Academy of Neurology Annual ...

Estrogen-containing combined hormonal contraceptives are not tied to vascular risk, such as stroke, in women with migraine ...

The FDA has granted marketing authorization to CT-132 for the preventive treatment of episodic migraine in patients aged 18 years and older.

FDA Cleared Nerivio® REN Wearable Offers Non-Drug Treatment Option for Millions of People With Migraine as Young as 8. NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- For millions o ...

Migraine disease affects millions of Americans, but treatments often cause side effects that hinder sufferers' ability to function.

The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive treatment of episodic migraine.

The US Food and Drug Administration (FDA) has approved Click Therapeutics’ CT-132 as the first prescription digital ...

For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged. These medications are proving to be highly effective for migraine ...

Holding announced that it has received approval of a New Drug Submission, NDS, from the Health Canada’s Pharmaceutical Drugs ...

Fremanezumab is a calcitonin-gene related peptide (CGRP) pathway monoclonal antibody that is FDA approved for adults with ...

Early identification of the cause of AKI is crucial to guarantee the best treatment and highest likelihood of recovery. The signs and symptoms of acute kidney injury can vary depending on the ...

Migraine medications often come with side effects. Learn how to minimize discomfort and find relief while managing migraine.